RxDoctor Payments Data

Rami Batniji

Facial Plastic Surgery · Newport Beach, CANPI 1467534644

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $281,148 and has fallen 75.0% since, to $70,291 in 2025. Among facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,009,209in general payments, 2019–2025

Across 644 payments — averaging $1567.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1M
  • Revance Therapeutics, Inc.$190
  • Acclarent, Inc$22
$25in research payments, 2019–2025

Across 1 payment — averaging $24.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$25

What the payments were for

  • Consulting fees$486,65448%
  • Speaking & faculty fees$433,82643%
  • Travel & lodging$74,6467%
  • Food & beverage$13,9051%
  • Education$1790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)634$1,008,996
Revance Therapeutics, Inc.9$190
Acclarent, Inc1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,009,209 in reported general payments places this provider in the 95th percentile of 120 facial plastic surgery providers in California.

See all facial plastic surgery providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate22$285
Methylprednisolone52$253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$238
Cephalexin30$146
Lorazepam31$80
Ondansetron Hcl27$76

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Newport Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →